However, Lp-PLA2 inhibition reduced risk of MCE in those with diabetes (HR 0.67 [0.50, 0.90]; p = 0.008) compared with those without diabetes (full model in ESM Table 12 and stratum-wise effect in Table 3). The gene discussed is PLA2G7; the disease is diabetes mellitus.